Introduction
Breast and ovarian cancers dramatically impact the lives of affected women and further place a significant economic burden on both their families and the health care system. Roughly 25% of familial breast and breast/ovarian cancer patients harbor a mutation in Breast Cancer Associated gene 1 (BRCA1). Long-term prospects for BRCA1-dependent basal-type breast cancer patients are poor, 1 mandating that elucidation of BRCA1 pathways remain a prominent research priority. BRCA1 is a tumor suppressor protein comprised in part of a N-terminal RING finger domain, two NLS motifs and a C-terminal BRCT domain. A significant source of information regarding BRCA1 function is predicated on its binding partners. For instance, BRCA1 associates with BARD1 (E3 ubiquitin ligase), BASC (DNA replication-associated repair), MRN (DNA damage sensor complex), BACH1/BRIP/FANCJ (DNA helicase), CBP/ p300-RNA polymerase II holoenzyme (acetyltransferase transcription activator) and many other factors. 2, 3 While this abundance of BRCA1-interactions reveals a plethora of subcomplexes and functions, it simultaneously complicates BRCA1 analyses. What is clear is that BRCA1-deficient cells exhibit chromosome aberrations that include whole chromosome duplications, translocations, chromosome breaks, elevated sister chromatid exchange rates and inter-sister gaps. [4] [5] [6] [7] Linking pleiotropic chromosomal effects to a singular underlying mechanism will provide critical new insights into the molecular basis of cancer and to BRCA1-dependent tumorigenesis in particular.
Fundamental for high fidelity chromosome segregation is the pairing of sister chromatids from DNA replication until anaphase onset. The pairing of sister chromatids, termed cohesion, requires the coordination of four activities (cohesins, deposition, regulators and establishment)-all of which are highly conserved through evolution. [8] [9] [10] Cohesins (Smc1, Smc3, Irr1/Scc3/Psc3/SA1/SA2 and Mcd1/Scc1/Rad21) maintain sister pairing from S phase until anaphase onset and resist poleward-pulling forces produced by the mitotic spindle (nomenclature indicative of either yeast, human, Drosophila, frog or worm). At least a subset of cohesins comprise a soluble ring-like complex that is thought to encompass each sister chromatid. [9] [10] [11] [12] [13] [14] Scc2/Mis4/Nipped-B/NIPBL and Scc4 function as a cohesin deposition complex that load cohesin ring-like complexes onto chromosomes. Cohesin deposition can occur throughout the cell cycle, but loading at least must occur in S phase with some evidence that loading prior to S phase also may be important. 11, [15] [16] [17] [18] [19] Regulating cohesin dynamics is accomplished by the antagonistic functions of Pds5/Spo76/BimD and WAPL/Rad61. Pds5 family members promote cohesion establishment during S-phase and antagonize cohesin proteolysis during M-phase. [20] [21] [22] [23] WAPL/Rad61 promotes cohesin removal early during M phase. WAPL-dependent cohesin release occurs prior to and independent from Esp1-directed cohesin proteolysis at anaphase onset. 24, 25 Ctf7 establishes cohesion between nascent sister chromatids during S-phase. 26, 27 Ctf7 establishment family members (Ctf7/Eco1/Eso1/Deco/EFO1,2/ ESCO1,2) do not maintain sister pairing nor promote cohesin deposition. [26] [27] [28] [29] [30] [31] Instead, a likely scenario is that these factors catalyze cohesin associations that tether together sister chromatids. 11, 32 Ctf7 binds numerous DNA replication factors including the DNA 
Linking Sister Chromatid Cohesion to Tumorigenesis
Studies from a number of model organisms establish that defects in sister chromatid cohesion result in massive chromosome missegregation, aneuploidy and gene mis-expression-all hallmarks of cancer progression. [8] [9] [10] In many ways, the link between sister chromatid pairing defects and cancer is conceptually satisfying (Fig. 1) . Properly paired sister chromatids supply a repair template required in response to DNA damage and may further provide structural fortification to resist chromosome breakage. 7, 42 Thus, defects in sister chromatid pairing eradicate high-fidelity DNA repair pathways and may serve as fragile sites that promote chromosomal translocations, truncations and subsequent gene mis-expression (as observed in BRCA1-deficient cells). Global loss of sister chromatid pairing produces whole chromosome duplications via mis-segregation. Finally, cohesion factors participate in higher-order heterochromatic complex formation. These complexes function as boundary elements of transcriptionally repressed domains and may further sequester factors important for enhancer-promoter activation, providing for additional mechanisms of gene mis-regulation. 43 There is now compelling evidence that cohesion is a critical factor in many forms of cancer. Human securin (a Pds1-like regulator of cohesin dissolution at anaphase onset) is the human proto-oncogene pituitary tumor-transforming gene (PTTG). PTTG exhibits tumor transforming activity in culture and is highly upregulated in human cancer cell lines. 44, 45 The establishment factor EFO2/ESCO2 is one of only ~12 cell cycle control genes that are highly upregulated in aggressive melanoma cells. 46 WAPL was characterized in drosophila as a heteochromatin regulator with subsequent studies revealing a role in pre-anaphase cohesin release. WAPL expression correlates tightly with oncogenesis in cervical malignancies. NIH3T3 cells expressing elevated WAPL levels produced tumors in 100% of injected nude mice, identifying WAPL as a potent oncogene. 24, 25 Thus, a significant body of evidence links mutations in cohesion pathways to a variety of cancers.
Linking BRCA1-Dependent Tumorigenesis to Cohesion
Is there evidence that BRCA1-dependent tumorigenesis operates through sister chromatid pairing reactions? While speculative, numerous studies suggest just such a link. 8 For instance, several BRCA1-binding partners play critical roles in sister chromatid cohesion. In a first example, BRCA1 binds to the DNA helicase BACH1 (also called FANCJ and BRIP1) which is required for BRCA1-dependent double strand break repair. [47] [48] [49] [50] In one study, a small number of breast cancer patients were found that harbor mutations in BACH1, but not mutations in either BRCA1 or BRCA2. This and other studies suggest that loss of BACH1 helicase activity is itself sufficient to predispose affected individuals to tumorigenesis. 49, 50 BACH1 mutations pre-dispose affected individuals not only to breast and ovarian cancer but also to Fanconi anemia. 51 At the cellular level, diminished BACH1 function results in chromosome aberrations that include inter-sister gaps (localized cohesion defects) similar to those found in cells deficient for BRCA1. 4, 52 Mutations in BACH1 homologs such as yeast Chl1 are entirely sufficient to produce sister chromatid cohesion defects and aneuploidy. [33] [34] [35] Moreover, the BACH1 yeast homolog Chl1 interacts both physically and genetically with the cohesion establishment factor Ctf7. 33 That mutation of a single DNA helicase results in cohesion-related cell aneuploidy is confirmed in a number of model organisms. 4, [33] [34] [35] [53] [54] [55] Knock-out mice homozygous null for RecQL4 (the helicase responsible for Rothmund-Thomson Syndrome or RTS) recapitulate RTS phenotypes including skin abnormalities, skeletal defects, aneuploidy and a pre-disposition to cancer. Significantly, cells from recql4 -/-mice exhibit dramatic cohesion defects-providing a clear and singular cohesion-based tumorigenic mechanism. 55 Other lines of evidence support the model that BRCA1-dependent tumorigenesis may act through sister chromatid pairing reactions. BRCA1 binds and functionally interacts with the human DNA repair MRN complex comprised of Mre11, Rad50 and Nbs1. 56, 57 A mutation in any one of the MRX complex component homologs (human Nbs1 is termed Xrs2 in yeast) produced significant cohesion defects that result in chromosome mis-segregation and aneuploidy. 54, 58 BLM (Bloom syndrome helicase) is another BRCA1-associated component that, when mutated, results in hypermutability, elevated rates of somatic recombination and predisposition to cancer. 56, 59 Analyses of the yeast homologs of BACH1, BLM and WRN helicases (Werner mutations results in premature aging) all confirm that homologs of BRCA1-associated DNA helicases play key roles in sister chromatid pairing mechanisms. 4, [33] [34] [35] 53, 54 In combination, BRCA1 associates with many factors that function in sister chromatid pairing. It is worth speculating that BRCA1-tumorigenesis may involve Ctf7 family members. First, human BRCA1 participates in complexes that contain the DNA helicase BACH1 and RFC subunits and BRCA1 is recruited to PCNA/RFC foci upon DNA damage. 4, 49, 50, [60] [61] [62] In all model organisms tested to date, Ctf7 exhibits multiple interactions with Chl1 (homolog of human BACH1), PCNA and all RFC complexes-including those implicated in DNA repair. 26, 33, 36, 37 Second, BRCA1 is part of CBP/p300 and SWI/SNF chromatin remodeling complexes that exhibit acetyltransferase activity. [63] [64] [65] Ctf7 family members are all acetyltransferases, lending indirect support for a model that this conserved activity may play a role in BRCA1-dependent functions. [28] [29] [30] [31] 66, 67 Third, cells harboring mutations in either BRCA1-or EFO/ESCO-related pathways exhibit inter-sister gaps and cohesion defects especially along heterochromatic and centromeric regions. 8, 11 That BRCA1 and Ctf7 family members share overlapping partners, exhibit similar activities in complex and, when mutated, produce aberrant chromosomal phenotypes provide for intriguing parallels.
Coming Full Circle-DNA Repair Induces Cohesion
In an unusual twist, recent evidence reveals that a reciprocal relationship exists between DNA repair and sister chromatid cohesion. Early evidence indicated that cohesion establishment only occurs during S phase. 26, 27 Subsequent studies indicated that DNA double strand breaks re-activate cohesion establishment pathways outside of S-phase. 16, 17 More recently, the Koshland and Sjogren labs provided evidence that DNA double strand breaks specifically re-activate Ctf7-dependent cohesion establishment activity and that this pairing occurs independent of the replication/repair fork. 40, 41 DNA damage-induced re-activation of Ctf7 requires Mec1/ATR (ataxia telangiectasia and Rad3 related) PI kinase checkpoint activity. Thus, a chicken and egg scenario emerges: cohesion is required for DNA repair and DNA damage induces new rounds of Ctf7-dependent cohesion establishment which in turn promotes efficient DNA repair.
Cohesion in Developmental Abnormalities
Sister chromatid pairing reactions are not just cancer-related. For instance, mutations in any one of the cohesion-related processes (cohesins, deposition, regulators and establishment) produce developmental manifestations. 43 Mutation of either human Scc2/NIPBL or Smc1 results in Cornelia de Lange Syndrome. [68] [69] [70] Cornelia de Lange Syndrome (CdLS) presents with developmental defects in multiple cell systems that result in heart defects, hearing impairments, microcephaly, missing digits and often severe mental retardation. Mutations in cohesion establishment factors such as EFO2/ESCO2 result in Roberts Syndrome-a recessive malady in which afflicted individuals exhibit severe growth retardation, craniofacial abnormalities, mental deficiencies and tetraphocomelia. EFO2/ESCO2 mutations also produce the related SC phocomelia which mimics thalidomide fetal effects but typically allows survival into adulthood. 31 Solving the mystery of whether cohesion defects will produce developmental abnormalities or tumors probably will require elucidating the roles of numerous factors including the cell type involved, mutation consequence (loss-of-function versus gain-of-function), or timing of mutagenesis (embryogenesis or in adult tissue).
Conclusions
In summary, a growing body of evidence suggests that altered sister chromatid pairing activities are integral to a number of human disease states including developmental abnormalities, pre-mature aging and cancer. Moreover, I speculate here that BRCA1 pathways are intimately linked to sister chromatid pairing reactions to affect a variety of chromosomal phenotypes. Thus, while BRCA1 associates with numerous complexes and participates in a number of activities, it may be that one underlying mechanism may indeed fit all.
